Delivery Order SPE2DB20D2104-SPE2DB22FQ67U
Award Date 10/8/21
Potential Completion Date 10/12/21
Potential Value $12K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $13,499.89 for the supply of RESTASIS 0.05% eye emulsion. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $6,944.92 for the supply of Restasis 0.05% eye emulsion. The award was made by the Defense Logistics Agency (DLA) on December 27, 2021, with a completion date of December 28, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,152.41 for the supply of RESTASIS 0.05% eye emulsion. The contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of September 9, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,800.80 for the supply of Restasis 0.05% eye emulsion. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a comprehensive range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the pharmaceutical product Restasis 0.05% eye emulsion. The contract has a ceiling value of $2,160.96 and an ultimate completion date of June 1, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of...
- The U.S. Defense Logistics Agency (DLA) awarded a $43,715.14 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Restasis 0.05% eye emulsion. The contract has an ultimate completion date of February 2, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,881.31 firm fixed-price contract is for the delivery of Restasis 0.05% eye emulsion, a specialty medication. The award has an ultimate completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of RESTASIS 0.05% eye emulsion. The $8,037.51 firm-fixed-price contract has a completion date of December 12, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,967.26 delivery order is for the supply of Restasis 0.05% eye emulsion, a specialty pharmaceutical product. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,862.34 firm-fixed-price delivery order is for the supply of Restasis 0.05% eye emulsion 30s, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...